查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509744

美國的泌尿科市場:規模，佔有率，趨勢分析(2024年～2030年):MedSuite

Urology Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more
出版日期: | 出版商: iData Research Inc. | 英文 537 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

美國泌尿外科市場規模預計將以 5.7% 的複合年增長率成長，到 2030 年將達到近 65 億美元。

隨著醫院繼續擴大對門診設施的收購以及集團採購組織 (GPO) 的影響力，泌尿科費用繼續下降，平均銷售價格 (ASP) 仍面臨持續壓力，可能會阻礙未來的市場成長。

NeoTract 的 UroLift (R) 於 2013 年在美國上市，用於治療良性前列腺增生 (BPH)，迅速受到泌尿科醫生的歡迎，並已擴展到歐洲、加拿大、澳大利亞等地區。受歡迎。這種微創手術恢復時間快，因此很有吸引力。 Teleflex 於 2017 年收購 NeoTract，受益於 Teleflex 廣泛的分銷網絡，加強了 UroLiftR 的市場滲透率。 2021 年 9 月，基於初步臨床成功，推出了 UroLift 高級組織控制 (ATC) (R) 和 UroLift (R) 2 系統，旨在提高病患安全並減輕後勤負擔。

本報告提供美國的泌尿科市場相關調查，提供市場概要，以及各市場區隔趨勢，推動市場要素及阻礙因素，競爭市場佔有率分析，及加入此市場的主要企業簡介等資訊。

目錄

摘要整理

調查手法

COVID-19對全球泌尿科市場的影響

  • 簡介
  • 地區簡介
  • 各市場區隔分析

疾病概要

  • 基本的解剖學
  • 病的治療和診斷
  • 患者的人口統計

產品評估

  • 簡介
  • 產品系列
  • 法規上的問題和回收
  • 臨床試驗

美國的泌尿科設備市場概要

  • 簡介
  • 市場概要與趨勢分析
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析
  • 合併和收購
  • 企業簡介
    • Becton Dickinson
    • Boston Scientific
    • Cardinal Health
    • Coloplast
    • Cook Medical
    • Elekta
    • Ethicon
    • Karl Storz
    • Laborie
    • Medline
    • Olympus
    • Siemens Healthineers
    • Teleflex
  • SWOT分析

尿失禁設備市場

結石管理設備市場

BPH治療設備市場

泌尿系統內視鏡市場

前列腺癌症治療設備市場

尿動態的設備市場

腎瘺設備市場

男性的生殖醫療市場

尿導管導引線市場

Product Code: iDATA_USUR24

CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.

Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.

Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.

Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.

Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

U.S. Urological Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Included

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE U.S. Urological Device Market

  • 2.1 Introduction
  • 2.2 Analysis By Market Segment
    • 2.2.1 Worst Case Scenario
    • 2.2.2 Base Case Scenario
    • 2.2.3 Best Case Scenario

Disease overview

  • 3.1 Basic Anatomy
    • 3.1.1 Urinary System
      • 3.1.1.1 Male Urinary System
      • 3.1.1.2 Female Urinary System
  • 3.2 Disease Treatment and Diagnostics
    • 3.2.1 Benign Prostatic Hyperplasia
    • 3.2.2 Urinary Incontinence
    • 3.2.3 Urinary Tract Infections
    • 3.2.4 Kidney Stones
    • 3.2.5 Bladder Prolapse
    • 3.2.6 Overactive Bladder
    • 3.2.7 Prostatitis
    • 3.2.8 Men's Reproductive Health
    • 3.2.9 Cancer
      • 3.2.9.1 Prostate Cancer
      • 3.2.9.2 Bladder Cancer
  • 3.3 Patient Demographics
    • 3.3.1 Benign Prostatic Hyperplasia
    • 3.3.2 Urinary Incontinence
    • 3.3.3 Urinary Tract Infections
    • 3.3.4 Kidney Stones
    • 3.3.5 Bladder Prolapse
    • 3.3.6 Overactive Bladder
    • 3.3.7 Prostatitis
    • 3.3.8 Men's Reproductive Health
    • 3.3.9 Cancer
      • 3.3.9.1 Prostate Cancer
      • 3.3.9.2 Bladder Cancer

Product Assessment

  • 4.1 Introduction
  • 4.2 Product Portfolios
    • 4.2.1 Urinary Incontinence
      • 4.2.1.1 Urinary Catheters
      • 4.2.1.1.1 Intermittent Catheters
      • 4.2.1.1.2 Foley Catheters
      • 4.2.1.1.3 Male External Catheters
      • 4.2.1.1.4 Female External Catheters
      • 4.2.1.2 Urethral Bulking Agents
      • 4.2.1.3 Female Incontinence Slings
      • 4.2.1.4 Male Implantable Devices
      • 4.2.1.4.1 Male Incontinence Slings
      • 4.2.1.4.2 Artificial Urinary Sphincters
      • 4.2.1.5 Urine Bags
      • 4.2.1.5.1 Leg Bags
      • 4.2.1.5.2 Bedside Drainage Bags
    • 4.2.2 Stone Management
      • 4.2.2.1 ESWL Equipment
      • 4.2.2.2 Intracorporeal Lithotripsy Equipment
      • 4.2.2.3 Holmium Lasers
      • 4.2.2.4 Stone Fragment Retrieval Devices
      • 4.2.2.5 Ureteral Stents
      • 4.2.2.6 Thulium Lasers and Fibers
    • 4.2.3 BPH Treatment
      • 4.2.3.1 TURP
      • 4.2.3.2 TUMT
      • 4.2.3.3 TUNA
      • 4.2.3.4 Prostatic Stents
      • 4.2.3.5 Novel BPH Solutions
      • 4.2.3.5.1 Rezum(TM)
      • 4.2.3.5.2 UroLift(R)
      • 4.2.3.5.3 iTind
      • 4.2.3.6 Laser BPH
      • 4.2.3.6.1 Photoselective Vaporization of the Prostate (PVP)
      • 4.2.3.6.2 Laser Vaporization of the Prostate
      • 4.2.3.6.3 Laser Ablation of the Prostate
      • 4.2.3.6.4 Laser Resection of the Prostate
      • 4.2.3.6.5 Laser Enucleation of the Prostate
    • 4.2.4 Urological Endoscopes
      • 4.2.4.1 Cystoscopes
      • 4.2.4.2 Ureteroscopes
      • 4.2.4.3 Resectoscopes
      • 4.2.4.4 Nephroscopes
    • 4.2.5 Prostate Cancer Treatment
      • 4.2.5.1 Brachytherapy
      • 4.2.5.1.1 HDR Implants
      • 4.2.5.1.2 LDR Implants
      • 4.2.5.2 Cryotherapy
    • 4.2.6 Urodynamics
      • 4.2.6.1 Urodynamic Equipment
      • 4.2.6.2 Urodynamic Consumables
      • 4.2.6.2.1 Water-Charged Catheters
      • 4.2.6.2.2 Air-Charged Catheters
      • 4.2.6.2.3 Fiber-Optic Catheters
    • 4.2.7 Nephrostomy
      • 4.2.7.1 Percutaneous Nephrostomy Drainage Tubes & Sets
      • 4.2.7.2 Nephrostomy Balloon Catheters
    • 4.2.8 Men's Reproductive Health
      • 4.2.8.1 Penile Implants
      • 4.2.8.1.1 Inflatable
      • 4.2.8.1.2 Malleable
      • 4.2.8.1.3 Vacuum
      • 4.2.8.2 Testicular Implants
    • 4.2.9 Urinary Guidewires
  • 4.3 Regulatory Issues and Recalls
    • 4.3.1 Urinary Incontinence Device Market FDA Recalls
    • 4.3.2 Stone Management Device Market FDA Recalls
    • 4.3.3 BPH Treatment Device Market FDA Recalls
    • 4.3.4 Urological Endoscope Market FDA Recalls
    • 4.3.5 Prostate Cancer Treatment Device Market FDA Recalls
    • 4.3.6 Nephrostomy Device Market FDA Recalls
    • 4.3.7 Men's Reproductive Health Device Market FDA Recalls
  • 4.4 Clinical Trials
    • 4.4.1 Urinary Incontinence Device Market Clinical Trials
    • 4.4.2 Stone Management Devices Market Clinical Trials
    • 4.4.3 BPH Treatment Device Market Clinical Trials
    • 4.4.4 Urological Endoscope Market Clinical Trials
    • 4.4.5 Prostate Cancer Treatment Device Market Clinical Trials
    • 4.4.6 Men's Reproductive Health Device Market Clinical Trials

U.S. Urological Device Market Overview

  • 5.1 Introduction
  • 5.2 Market Overview & Trend Analysis
  • 5.3 Drivers and Limiters
    • 5.3.1 Market Drivers
    • 5.3.2 Market Limiters
  • 5.4 Competitive Market Share Analysis
  • 5.5 Mergers and Acquisitions
  • 5.6 Company Profiles
    • 5.6.1 Becton Dickinson
    • 5.6.2 Boston Scientific
    • 5.6.3 Cardinal Health
    • 5.6.4 Coloplast
    • 5.6.5 Cook Medical
    • 5.6.6 Elekta
    • 5.6.7 Ethicon
    • 5.6.8 Karl Storz
    • 5.6.9 Laborie
    • 5.6.10 Medline
    • 5.6.11 Olympus
    • 5.6.12 Siemens Healthineers
    • 5.6.13 Teleflex
  • 5.7 SWOT Analysis
    • 5.7.1 Becton Dickinson
    • 5.7.2 Boston Scientific
    • 5.7.3 Cardinal Health
    • 5.7.4 Coloplast
    • 5.7.5 Cook Medical
    • 5.7.6 Elekta
    • 5.7.7 Ethicon
    • 5.7.8 Karl Storz
    • 5.7.9 Laborie
    • 5.7.10 Medline
    • 5.7.11 Olympus
    • 5.7.12 Siemens Healthineers
    • 5.7.13 Teleflex

Procedure Numbers

  • 6.1 Procedure Codes Investigated
  • 6.2 Procedure Overview
    • 6.2.1 Urinary Incontinence Management Procedures
      • 6.2.1.1 Male Urinary Incontinence Management Procedures
      • 6.2.1.2 Female Urinary Incontinence Management Procedures
    • 6.2.2 Stone Management Procedures
      • 6.2.2.1 ESWL Procedures
      • 6.2.2.2 Transurethral Procedures
      • 6.2.2.3 Ureteral Stent Procedures
      • 6.2.2.4 PCNL Procedures
    • 6.2.3 Ureteroscopy Procedures
    • 6.2.4 Cystoscopy Procedures
    • 6.2.5 BPH Procedures
      • 6.2.5.1 BPH Patient Statistics
      • 6.2.5.2 BPH Procedures by Segment
      • 6.2.5.3 BPH Procedures by Care Setting
      • 6.2.5.3.1 Hospital Procedures
      • 6.2.5.3.2 Ambulatory Surgery Center (ASC) Procedures
      • 6.2.5.3.3 Office Procedures
    • 6.2.6 Prostate Cancer Treatment Procedures
      • 6.2.6.1 Prostate Cancer Patient Statistics
      • 6.2.6.2 Prostate Cancer Treatment Procedures
      • 6.2.6.2.1 Watchful Waiting Procedures
      • 6.2.6.2.2 Prostatectomy Procedures
      • 6.2.6.2.3 Ablation Procedures
      • 6.2.6.2.4 Radiation Therapy Procedures
    • 6.2.7 Urodynamic Testing Procedures
      • 6.2.7.1 Cystometrogram Procedures
      • 6.2.7.2 Uroflowmetry Procedures
    • 6.2.8 Nephrostomy Procedures
    • 6.2.9 Erectile Dysfunction Management Procedures

Urinary Incontinence Device Market

  • 7.1 Introduction
  • 7.2 Market Overview
  • 7.3 Market Analysis and Forecast
    • 7.3.1 Urinary Catheter Market
      • 7.3.1.1 Intermittent Catheter Market
      • 7.3.1.1.1 Coated Intermittent Catheter Market
      • 7.3.1.1.2 Uncoated Intermittent Catheter Market
      • 7.3.1.1.3 Closed-System Intermittent Catheter Market
      • 7.3.1.2 Foley Catheter Market
      • 7.3.1.2.1 Latex Foley Catheter Market
      • 7.3.1.2.2 Latex-Free Foley Catheter Market
      • 7.3.1.2.3 Closed-System Foley Tray Market
      • 7.3.1.3 External Catheter Market
      • 7.3.1.3.1 Male External Catheter Market
      • 7.3.1.3.2 Female External Catheter Market
    • 7.3.2 Urethral Bulking Agent Market
      • 7.3.2.1 Male Urethral Bulking Agent Market
      • 7.3.2.2 Female Urethral Bulking Agent Market
    • 7.3.3 Incontinence Management Device Market
      • 7.3.3.1 Female Incontinence Sling Market
      • 7.3.3.2 Male Implantable Incontinence Device Market
      • 7.3.3.2.1 Male Incontinence Sling Market
      • 7.3.3.2.2 Male Artificial Urinary Sphincter Market
    • 7.3.4 Urinary Bag Market
      • 7.3.4.1 Bedside Urine Drainage Bag Market
      • 7.3.4.2 Leg Urine Drainage Bag Market
  • 7.4 Drivers and Limiters
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 Competitive Market Share Analysis

Stone Management Device Market

  • 8.1 Introduction
  • 8.2 Market Overview
  • 8.3 Market Analysis and Forecast
    • 8.3.1 ESWL Equipment Market
    • 8.3.2 ISWL Equipment Market
    • 8.3.3 Holmium Laser Market
      • 8.3.3.1 Holmium Laser Equipment Market
      • 8.3.3.1.1 High-Power Holmium Laser Equipment Market
      • 8.3.3.1.2 Low-Power Holmium Laser Equipment Market
      • 8.3.3.2 Holmium Laser Fiber Market
      • 8.3.3.2.1 Reusable Holmium Laser Fiber Market
      • 8.3.3.2.2 Single-Use Holmium Laser Fiber Market
    • 8.3.4 Thulium Laser Market
      • 8.3.4.1 Thulium Laser Equipment Market
      • 8.3.4.2 Thulium Laser Fiber Market
    • 8.3.5 Stone Fragment Retrieval Device Market
      • 8.3.5.1 Nitinol Stone Fragment Retrieval Device Market
      • 8.3.5.2 Stainless-Steel Stone Fragment Retrieval Device Market
    • 8.3.6 Ureteral Stent Market
    • 8.3.7 Access Sheath Market
  • 8.4 Drivers and Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

BPH Treatment Device Market

  • 9.1 Introduction
    • 9.1.1 Treatments
      • 9.1.1.1 TURP
      • 9.1.1.2 Minimally Invasive Treatments
      • 9.1.1.3 Laser BPH Treatments
      • 9.1.1.3.1 Photoselective Vaporization of the Prostate (PVP)
      • 9.1.1.3.2 Laser Vaporization of the Prostate
      • 9.1.1.3.3 Laser Ablation of the Prostate
      • 9.1.1.3.4 Laser Resection of the Prostate
      • 9.1.1.3.5 Laser Enucleation of the Prostate
    • 9.1.2 Comparison of TURP and Laser BPH Procedures
    • 9.1.3 Emerging Technologies
  • 9.2 Market Overview
  • 9.3 Market Analysis and Forecast
    • 9.3.1 TURP Market
      • 9.3.1.1 Total Monopolar Electrode Market
      • 9.3.1.1.1 Monopolar Electrode Loop Market
      • 9.3.1.1.2 Monopolar Coagulating Resector Electrode Market
      • 9.3.1.1.3 Monopolar Vaporizing Electrode Market
      • 9.3.1.1.4 Other Monopolar Electrode Device Market
      • 9.3.1.2 Total Bipolar Electrode Market
      • 9.3.1.2.1 Bipolar Electrode Loop Market
      • 9.3.1.2.2 Bipolar Vaporizing Electrode Market
      • 9.3.1.2.3 Other Bipolar Electrode Device Market
    • 9.3.2 TUMT Market
      • 9.3.2.1 TUMT Equipment Market
      • 9.3.2.2 TUMT Consumables Market
    • 9.3.3 TUNA Market
      • 9.3.3.1 TUNA Equipment Market
      • 9.3.3.2 TUNA Consumables Market
    • 9.3.4 Temporary Prostatic Stent Market
    • 9.3.5 Laser BPH Market
      • 9.3.5.1 Laser BPH Equipment Market
      • 9.3.5.1.1 High-Power Holmium Laser Equipment Market
      • 9.3.5.1.2 Thulium Laser Equipment Market
      • 9.3.5.2 Laser BPH Fiber Market
      • 9.3.5.2.1 Water Targeting Fiber Market
      • 9.3.5.2.2 Hemoglobin Targeting Fiber Market
    • 9.3.6 UroLift Market
    • 9.3.7 Rezum Market
      • 9.3.7.1 Rezum Equipment Market
      • 9.3.7.2 Rezum Consumables Market
    • 9.3.8 iTind Market
  • 9.4 Drivers and Limiters
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 Competitive Market Share Analysis

Urological Endoscope Market

  • 10.1 Introduction
  • 10.2 Market Overview
    • 10.2.1 Urological Endoscope Market by Segment
    • 10.2.2 Urological Endoscope Market by Condition
  • 10.3 Market Analysis and Forecast
    • 10.3.1 Urological Endoscope Market
    • 10.3.2 Cystoscope Market
      • 10.3.2.1 Single-Use Cystoscope Market
      • 10.3.2.2 Reusable Cystoscope Market
      • 10.3.2.2.1 Reusable Rigid Cystoscope Market
      • 10.3.2.2.2 Reusable Flexible Cystoscope Market
      • 10.3.2.2.3 New Flexible Cystoscope Market
      • 10.3.2.2.4 Refurbished Flexible Cystoscope Market
    • 10.3.3 Ureteroscope Market
      • 10.3.3.1 Single-Use Flexible Ureteroscope Market
      • 10.3.3.2 Reusable Ureteroscope Market
      • 10.3.3.2.1 Semi-Rigid Ureteroscope Market
      • 10.3.3.2.2 Reusable Flexible Ureteroscope Market
      • 10.3.3.2.3 New Flexible Ureteroscope Market
      • 10.3.3.2.4 Refurbished Flexible Ureteroscope Market
    • 10.3.4 Resectoscope Market
      • 10.3.4.1 New Resectoscope Market
      • 10.3.4.2 Refurbished Resectoscope Market
    • 10.3.5 Nephroscope Market
      • 10.3.5.1 New Nephroscope Market
      • 10.3.5.2 Refurbished Nephroscope Market
  • 10.4 Drivers and Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

Prostate Cancer Treatment Device Market

  • 11.1 Introduction
  • 11.2 Market Overview
  • 11.3 Market Analysis and Forecast
    • 11.3.1 Brachytherapy Device Market
      • 11.3.1.1 HDR Brachytherapy Market
      • 11.3.1.1.1 Afterloader Market
      • 11.3.1.1.2 Afterloader Service Market
      • 11.3.1.2 LDR Brachytherapy Market
      • 11.3.1.2.1 LDR Seed Market
      • 11.3.1.2.2 LDR Needle Market
    • 11.3.2 Cryotherapy Ablation Device Market
      • 11.3.2.1 Cryotherapy Ablation Device Market
      • 11.3.2.2 Cryotherapy Ablation Device Rental Market
      • 11.3.2.3 Cryotherapy Ablation Probe Market
    • 11.3.3 Hydrogel Rectal Spacer Device Market
  • 11.4 Drivers and Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Urodynamic Equipment Market

  • 12.1 Introduction
  • 12.2 Market Overview
  • 12.3 Market Analysis and Forecast
    • 12.3.1 Urodynamic Equipment Market
      • 12.3.1.1 Hospital Urodynamic Capital Equipment Market
      • 12.3.1.2 Medical Office Urodynamic Capital Equipment Market
    • 12.3.2 Urodynamic Consumables Market
      • 12.3.2.1 Air-Charged Catheter Market
      • 12.3.2.2 Water-Filled Catheter Market
      • 12.3.2.3 Fiber Optic Catheter Market
  • 12.4 Drivers and Limiters
    • 12.4.1 Market Drivers
    • 12.4.2 Market Limiters
  • 12.5 Competitive Market Share Analysis

Nephrostomy Device Market

  • 13.1 Introduction
  • 13.2 Market Overview
  • 13.3 Market Analysis and Forecast
    • 13.3.1 Percutaneous Nephrostomy Set Market
    • 13.3.2 Nephrostomy Balloon Catheter Market
    • 13.3.3 Nephrostomy Drainage Tube Market
  • 13.4 Drivers and Limiters
    • 13.4.1 Market Drivers
    • 13.4.2 Market Limiters
  • 13.5 Competitive Market Share Analysis

Men's Reproductive Health Market

  • 14.1 Introduction
    • 14.1.1 Low Testosterone Pharmaceutical Delivery
  • 14.2 Market Overview
  • 14.3 Market Analysis and Forecast
    • 14.3.1 Inflatable Erectile Dysfunction Device Market
    • 14.3.2 Malleable Erectile Dysfunction Device Market
    • 14.3.3 Vacuum Erection Device Market
    • 14.3.4 Testicular Implant Market
  • 14.4 Drivers and Limiters
    • 14.4.1 Market Drivers
    • 14.4.2 Market Limiters
  • 14.5 Competitive Market Share Analysis

Urinary Guidewire Market

  • 15.1 Introduction
  • 15.2 Market Analysis and Forecast
  • 15.3 Drivers and Limiters
    • 15.3.1 Market Drivers
    • 15.3.2 Market Limiters
  • 15.4 Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 1-1: Urological Device Market by Segment, U.S., 2023 - 2030
  • Chart 1-2: Urological Device Market Overview, U.S., 2023 & 2030
  • Chart 2-1: Multi-Scenario Urological Device Market Forecast, U.S., 2020 - 2030 (US$M)
  • Chart 5-1: Urological Device Market by Segment, U.S., 2020 - 2030
  • Chart 5-2: Leading Competitors, Urological Device Market, U.S., 2023
  • Chart 6-1: Urology Market Procedures by Segment, U.S., 2020 - 2030
  • Chart 7-1: Urinary Incontinence Device Market by Segment, U.S., 2020 - 2030
  • Chart 7-2: Leading Competitors, Urinary Incontinence Device Market, U.S., 2023
  • Chart 8-1: Stone Management Device Market by Segment, U.S., 2020 - 2030
  • Chart 8-2: Leading Competitors, Stone Management Device Market, U.S., 2023
  • Chart 9-1: BPH Treatment Device Market by Segment, U.S., 2020 - 2030
  • Chart 9-2: Leading Competitors, BPH Treatment Device Market, U.S., 2023
  • Chart 10-1: Urological Endoscope Market by Segment, U.S., 2020 - 2030
  • Chart 10-2: Urological Endoscope Market by Condition, U.S., 2020 - 2030
  • Chart 10-3: Leading Competitors, Urological Endoscope Market, U.S., 2023
  • Chart 11-1: Prostate Cancer Treatment Device Market by Segment, U.S., 2020 - 2030
  • Chart 11-2: Leading Competitors, Prostate Cancer Treatment Device Market, U.S., 2023
  • Chart 12-1: Urodynamic Equipment Market by Segment, U.S., 2020 - 2030
  • Chart 12-2: Leading Competitors, Urodynamic Equipment Market, U.S., 2023
  • Chart 13-1: Nephrostomy Device Market by Segment, U.S., 2020 - 2030
  • Chart 13-2: Leading Competitors, Nephrostomy Device Market, U.S., 2023
  • Chart 14-1: Men's Reproductive Health Market by Segment, U.S., 2020 - 2030
  • Chart 14-2: Leading Competitors, Men's Reproductive Health Market, U.S., 2023
  • Chart 15-1: Urinary Guidewire Market, U.S., 2020 - 2030
  • Chart 15-2: Leading Competitors, Urinary Guidewire Market, U.S., 2023

LIST OF FIGURES

  • Figure 1-1: Urological Device Market Share Ranking by Segment, U.S., 2023 (1 of 2)
  • Figure 1-2: Urological Device Market Share Ranking by Segment, U.S., 2023 (2 of 2)
  • Figure 1-3: Companies Researched in This Report (1 of 2)
  • Figure 1-4: Companies Researched in This Report (2 of 2)
  • Figure 1-5: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2)
  • Figure 1-6: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2)
  • Figure 1-7: Recent Events in the Urological Device Market, U.S., 2020 - 2024
  • Figure 1-8: Urological Device Procedures Covered (1 of 3)
  • Figure 1-9: Urological Device Procedures Covered (2 of 3)
  • Figure 1-10: Urological Device Procedures Covered (3 of 3)
  • Figure 1-11: Procedure Codes Investigated
  • Figure 1-12: Urological Device Markets Covered (1 of 6)
  • Figure 1-13: Urological Device Markets Covered (2 of 6)
  • Figure 1-14: Urological Device Markets Covered (3 of 6)
  • Figure 1-15: Urological Device Markets Covered (4 of 6)
  • Figure 1-16: Urological Device Markets Covered (5 of 6)
  • Figure 1-17: Urological Device Markets Covered (6 of 6)
  • Figure 1-18: Key Report Updates
  • Figure 1-19: Version History
  • Figure 2-1: Urological Device Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 2-2: Urological Device Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 2-3: Urological Device Market by Segment, Base Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 2-4: Urological Device Market by Segment, Base Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 2-5: Urological Device Market by Segment, Best Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 2-6: Urological Device Market by Segment, Best Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 4-1: Urinary Incontinence Treatments by Company (1 of 2)
  • Figure 4-2: Urinary Incontinence Treatments by Company (2 of 2)
  • Figure 4-3: Stone Management Devices by Company (1 of 4)
  • Figure 4-4: Stone Management Devices by Company (2 of 4)
  • Figure 4-5: Stone Management Devices by Company (3 of 4)
  • Figure 4-6: Stone Management Devices by Company (4 of 4)
  • Figure 4-7: BPH Treatments by Company
  • Figure 4-8: Urological Endoscopes by Company (1 of 2)
  • Figure 4-9: Urological Endoscopes by Company (2 of 2)
  • Figure 4-10: Prostate Cancer Treatments by Company
  • Figure 4-11: Urodynamic Equipment and Consumables by Company
  • Figure 4-12: Nephrostomy Devices by Company
  • Figure 4-13: Men's Reproductive Health Devices by Company
  • Figure 4-14: Urinary Guidewires by Company
  • Figure 4-15: Class 2 Device Recall BARD Magic3 GO
  • Figure 4-16: Class 2 Device Recall BULKAMID, URETHRAL BULKING SYSTEM
  • Figure 4-17: Class 2 Device Recall COAPTITE
  • Figure 4-18: Class 2 Device Recall Medline Silicone Foley catheter
  • Figure 4-19: Class 2 Device Recall SureStep
  • Figure 4-20: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone
  • Figure 4-21: Class 3 Device Recall Teleflex MEDICAL RuSCH One piece Male External Medium Catheter W/O Tape
  • Figure 4-22: Class 2 Device Recall AMS 800 Artificial Urinary Sphincter AMS 800 Belt Cuff
  • Figure 4-23: Class 3 Device Recall RUSCH Urinary Drainage bag
  • Figure 4-24: Class 2 Device Recall Rusch EasyCath Kit
  • Figure 4-25: Class 2 Device Recall UroPass Ureteral Access Sheath
  • Figure 4-26: Class 2 Device Recall Cook Medical Kwart RetroInject Ureteral Stent
  • Figure 4-27: Class 2 Device Recall Contour VL Ureteral Stent Set
  • Figure 4-28: Class 2 Device Recall Cook Medical
  • Figure 4-29: Class 2 Device Recall Polaris Ultra Ureteral Stent Set
  • Figure 4-30: Class 2 Device Recall Percuflex Plus Ureteral Stent Set
  • Figure 4-31: Class 2 Device Recall Stretch VL Ureteral Stent Set
  • Figure 4-32: Class 2 Device Recall Universa Firm Ureteral Stent
  • Figure 4-33: Class 2 Device Recall Universa Soft Ureteral Stent
  • Figure 4-34: Class 2 Device Recall SofFlex Double Pigtail Ureteral Stent
  • Figure 4-35: Class 2 Device Recall Urolift System
  • Figure 4-36: Class 3 Device Recall GreenLight HPSEA Laser Fibers
  • Figure 4-37: Class 2 Device Recall MoXy Laser Fiber
  • Figure 4-38: Class 2 Device Recall AURIGA 30 BRAZIL ZERO COST SYSTEM
  • Figure 4-39: Class 2 Device Recall Dornier
  • Figure 4-40: Class 2 Device Recall Olympus
  • Figure 4-41: Class 2 Device Recall OLYMPUS HF Resection Electrodes
  • Figure 4-42: Class 2 Device Recall KARL STORZ Flexible Video CystoUrethroscopes (CVIEW)
  • Figure 4-43: Class 2 Device Recall Flexible Cystoscope
  • Figure 4-44: Class 2 Device Recall SpaceOAR Vue System
  • Figure 4-45: Class 2 Device Recall IcePearl 2.1 CX 90 Cyroablation Needles
  • Figure 4-46: Class 2 Device Recall IceSphere" Cryoablation Needles
  • Figure 4-47: Class 2 Device Recall VisualICE MRI MCP
  • Figure 4-48: Class 2 Device Recall Visual ICE Cryoablation System
  • Figure 4-49: Class 2 Device Recall Percutaneous Neonatal Pigtail Nephrostomy Set and Pediatric Nephrostomy Stent Set
  • Figure 4-50: Class 2 Device Recall Percutaneous Pigtail Nephrostomy Set
  • Figure 4-51: Class 2 Device Recall Percutaneous Malecot Nephrostomy Set
  • Figure 4-52: Class 2 Device Recall Percutaneous Entry Set
  • Figure 4-53: Class 2 Device Recall Torosa
  • Figure 4-54: Class 2 Device Recall the AMS 700 Inflatable Penile Prosthesis
  • Figure 4-55: Class 2 Device Recall Titan Pump
  • Figure 4-56: Class 2 Device Recall AMS 700 Inflatable Penile Prosthesis
  • Figure 4-57: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone
  • Figure 4-58: Post-Market Clinical Follow-Up on TVT EXACT(R) Continence System
  • Figure 4-59: Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI during Minimally Invasive Sacrocolpopexy (SASS)
  • Figure 4-60: Artificial Urinary Sphincter Clinical Outcomes (AUSCO)
  • Figure 4-61: e۰Sense(R) Catheter Clinical Investigation
  • Figure 4-62: Investigation of Non-CE Marked Intermittent Catheters for Females
  • Figure 4-63: Exploratory Study of a New Urine Collection Device for Men
  • Figure 4-64: Investigation of New Intermittent Catheters in Healthy Volunteers
  • Figure 4-65: Safety and Device Performance of the Uriprene(R) Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy (URIPRENE)
  • Figure 4-66: The RELIEF(TM) Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position
  • Figure 4-67: Double-J PLUS Postmarket Registry
  • Figure 4-68: A Randomized, International Study to Assess the Safety of iTind Compared to UroLift
  • Figure 4-69: Comparing UroLift Experience Against Rezum
  • Figure 4-70: A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men with Urinary Symptoms Secondary to Prostate Enlargement
  • Figure 4-71: UroLift System with SAbR for Prostate Cancer and BPH
  • Figure 4-72: Comparing UroLift Experience Against Rezum (CLEAR)
  • Figure 4-73: To Evaluate the Feasibility, Preliminary Safety and Performance of Rezum System in BPH Treatment in China
  • Figure 4-74: Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi
  • Figure 4-75: Prospective Evaluation of the LithoVue Elite Ureteroscope
  • Figure 4-76: Effectiveness of Ambu(R) aScope(TM) 4 Cysto With the aView(TM) 2 Advance for Flexible Cystoscopy
  • Figure 4-77: Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
  • Figure 4-78: Evaluation of Performance and Safety of Ambu(R) aScope(TM) 4 Cysto and aView(TM) Urologia for Flexible Cystoscopy
  • Figure 4-79: Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
  • Figure 4-80: Focal Ablation with Focal Cryotherapy or HIFU for the Treatment of Men with Localized Prostate Cancer
  • Figure 4-81: Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer
  • Figure 4-82: LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono)
  • Figure 4-83: Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients with Prostate Cancer
  • Figure 4-84: Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants
  • Figure 4-85: Penile Prosthesis in Patients with Erectile Dysfunction
  • Figure 4-86: Safety and Efficacy Study of USTRAP(TM) in Male Urinary Incontinence (PROSPECT)
  • Figure 4-87: Rigicon Infla10(R) Three-Piece Inflatable Penile Prosthesis
  • Figure 5-1: Urological Device Market by Segment, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 5-2: Urological Device Market by Segment, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 5-3: Leading Competitors, Urological Device Market, U.S., 2023 (1 of 2)
  • Figure 5-4: Leading Competitors, Urological Device Market, U.S., 2023 (2 of 2)
  • Figure 5-5: SWOT Analysis, Becton Dickinson
  • Figure 5-6: SWOT Analysis, Boston Scientific
  • Figure 5-7: SWOT Analysis, Cardinal Health
  • Figure 5-8: SWOT Analysis, Coloplast
  • Figure 5-9: SWOT Analysis, Cook Medical
  • Figure 5-10: SWOT Analysis, Elekta
  • Figure 5-11: SWOT Analysis, Ethicon
  • Figure 5-12: SWOT Analysis, Karl Storz
  • Figure 5-13: SWOT Analysis, Laborie
  • Figure 5-14: SWOT Analysis, Medline
  • Figure 5-15: SWOT Analysis, Olympus
  • Figure 5-16: SWOT Analysis, Siemens
  • Figure 5-17: SWOT Analysis, Teleflex
  • Figure 6-1: Procedure Codes Investigated, U.S., 2023
  • Figure 6-2: Urological Procedures by Segment, U.S., 2020 - 2030 (1 of 2)
  • Figure 6-3: Urological Procedures by Segment, U.S., 2020 - 2030 (2 of 2)
  • Figure 6-4: Urinary Incontinence Management Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-5: Male Urinary Incontinence Management Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-6: Female Urinary Incontinence Management Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-7: Stone Management Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-8: ESWL Procedures, U.S., 2020 - 2030
  • Figure 6-9: Transurethral Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-10: Ureteral Stent Procedures, U.S., 2020 - 2030
  • Figure 6-11: PCNL Procedures, U.S., 2020 - 2030
  • Figure 6-12: Ureteroscopy Procedures by Device Type, U.S., 2020 - 2030
  • Figure 6-13: Cystoscopy Procedures by Device Type, U.S., 2020 - 2030
  • Figure 6-14: BPH Patient Statistics, U.S., 2020 - 2030
  • Figure 6-15: BPH Procedures by Segment, U.S., 2020 - 2030 (1 of 2)
  • Figure 6-16: BPH Procedures by Segment, U.S., 2020 - 2030 (2 of 2)
  • Figure 6-17: BPH Procedures by Care Setting, U.S., 2020 - 2030
  • Figure 6-18: BPH Procedures by Care Setting (Hospital), U.S., 2020 -2030 (1 of 2)
  • Figure 6-19: BPH Procedures by Care Setting (Hospital), U.S., 2020 -2030 (2 of 2)
  • Figure 6-20: BPH Procedures by Care Setting (ASC), U.S., 2020 -2030 (1 of 2)
  • Figure 6-21: BPH Procedures by Care Setting (ASC), U.S., 2020 -2030 (2 of 2)
  • Figure 6-22: BPH Procedures by Care Setting (Office), U.S., 2020 -2030 (1 of 2)
  • Figure 6-23: BPH Procedures by Care Setting (Office), U.S., 2020 -2030 (2 of 2)
  • Figure 6-24: BPH Patient Statistics, U.S., 2020 - 2030
  • Figure 6-25: Prostate Cancer Treatment Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-26: Watchful Waiting Procedures, U.S., 2020 - 2030
  • Figure 6-27: Prostatectomy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-28: Open Prostatectomy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-29: Ablation Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-30: Radiation Therapy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-31: HDR Brachytherapy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-32: LDR Brachytherapy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-33: External Radiation Therapy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-34: Urodynamic Testing Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-35: Cystometrogram Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-36: Uroflowmetry Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-37: Nephrostomy Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-38: Erectile Dysfunction Management Procedures by Segment, U.S., 2020 - 2030
  • Figure 7-1: Urinary Incontinence Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-2: Urinary Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-3: Intermittent Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-4: Total Intermittent Catheter Market, U.S., 2020 - 2030
  • Figure 7-5: Coated Intermittent Catheter Market, U.S., 2020 - 2030
  • Figure 7-6: Uncoated Intermittent Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-7: Uncoated Latex-Free Intermittent Catheter Market, U.S., 2020 - 2030
  • Figure 7-8: Uncoated Latex Intermittent Catheter Market, U.S., 2020 - 2030
  • Figure 7-9: Closed-System Intermittent Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-10: Gel Closed-System Intermittent Catheter Market, U.S., 2020 - 2030
  • Figure 7-11: Hydrophilic and Antimicrobial Closed-System Intermittent Catheter Market, U.S., 2020 - 2030
  • Figure 7-12: Foley Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-13: Total Foley Catheter Market, U.S., 2020 - 2030
  • Figure 7-14: Latex Foley Catheter Market, U.S., 2020 - 2030
  • Figure 7-15: Latex-Free Foley Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-16: Total Latex-Free Foley Catheter Market, U.S., 2020 - 2030
  • Figure 7-17: Uncoated Latex-Free Foley Catheter Market, U.S., 2020 - 2030
  • Figure 7-18: Coated Latex-Free Foley Catheter Market, U.S., 2020 - 2030
  • Figure 7-19: Closed-System Foley Tray Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-20: Total Closed-System Foley Tray Market, U.S., 2020 - 2030
  • Figure 7-21: Conventional Closed-System Foley Tray Market, U.S., 2020 - 2030
  • Figure 7-22: Antimicrobial Closed-System Foley Tray Market, U.S., 2020 - 2030
  • Figure 7-23: External Catheter Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-24: Total External Catheter Market, U.S., 2020 - 2030
  • Figure 7-25: Male External Catheter Market, U.S., 2020 - 2030
  • Figure 7-26: Female External Catheter Market, U.S., 2020 - 2030
  • Figure 7-27: Urethral Bulking Agent Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-28: Total Urethral Bulking Agent Market, U.S., 2020 - 2030
  • Figure 7-29: Male Urethral Bulking Agent Market, U.S., 2020 - 2030
  • Figure 7-30: Female Urethral Bulking Agent Market, U.S., 2020 - 2030
  • Figure 7-31: Incontinence Management Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-32: Total Incontinence Management Device Market, U.S., 2020 - 2030
  • Figure 7-33: Female Incontinence Sling Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-34: Total Female Incontinence Sling Market, U.S., 2020 - 2030
  • Figure 7-35: Transvaginal Tape Female Incontinence Sling Market, U.S., 2020 - 2030
  • Figure 7-36: Transobturator Female Incontinence Sling Market, U.S., 2020 - 2030
  • Figure 7-37: Single-Incision Female Incontinence Sling Market, U.S., 2020 - 2030
  • Figure 7-38: Male Implantable Incontinence Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-39: Total Male Implantable Incontinence Device Market, U.S., 2020 - 2030
  • Figure 7-40: Male Incontinence Sling Market, U.S., 2020 - 2030
  • Figure 7-41: Male Artificial Urinary Sphincter Market, U.S., 2020 - 2030
  • Figure 7-42: Urinary Bag Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7-43: Total Urinary Bag Market, U.S., 2020 - 2030
  • Figure 7-44: Bedside Urine Drainage Bag Market, U.S., 2020 - 2030
  • Figure 7-45: Leg Urine Drainage Bag Market, U.S., 2020 - 2030
  • Figure 7-46: Leading Competitors, Urinary Incontinence Device Market, U.S., 2023
  • Figure 7-47: Leading Competitors, Urinary Catheter Market, U.S., 2023
  • Figure 7-48: Leading Competitors, Incontinence Management Device Market, U.S., 2023
  • Figure 8-1: Stone Management Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 8-2: ESWL Equipment Market, U.S., 2020 - 2030
  • Figure 8-3: ISWL Equipment Market, U.S., 2020 - 2030
  • Figure 8-4: Holmium Laser Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 8-5: Holmium Laser Equipment Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 8-6: Total Holmium Laser Equipment Market, U.S., 2020 - 2030
  • Figure 8-7: High-Power Holmium Laser Equipment Market, U.S., 2020 - 2030
  • Figure 8-8: Low-Power Holmium Laser Equipment Market, U.S., 2020 - 2030
  • Figure 8-9: Holmium Laser Fiber Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 8-10: Total Holmium Laser Fiber Market, U.S., 2020 - 2030
  • Figure 8-11: Reusable Holmium Laser Fiber Market, U.S., 2020 - 2030
  • Figure 8-12: Single-Use Holmium Laser Fiber Market, U.S., 2020 - 2030
  • Figure 8-13: Thulium Laser Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 8-14: Thulium Laser Equipment Market, U.S., 2020 - 2030
  • Figure 8-15: Thulium Laser Fiber Market, U.S., 2020 - 2030
  • Figure 8-16: Stone Fragment Retrieval Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 8-17: Total Stone Fragment Retrieval Device Market, U.S., 2020 - 2030
  • Figure 8-18: Nitinol Stone Fragment Retrieval Device Market, U.S., 2020 - 2030
  • Figure 8-19: Stainless-Steel Stone Fragment Retrieval Device Market, U.S., 2020 - 2030
  • Figure 8-20: Ureteral Stent Market, U.S., 2020 - 2030
  • Figure 8-21: Access Sheath Market Stent Market, U.S., 2020 - 2030
  • Figure 8-22: Leading Competitors, Stone Management Device Market, U.S., 2023
  • Figure 9-1: BPH Treatment Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-2: TURP Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-3: Monopolar Electrode Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-4: Total Monopolar Electrode Market, U.S., 2020 - 2030
  • Figure 9-5: Monopolar Electrode Loop Market, U.S., 2020 - 2030
  • Figure 9-6: Monopolar Coagulating Resector Electrode Market, U.S., 2020 - 2030
  • Figure 9-7: Monopolar Vaporizing Electrode Market, U.S., 2020 - 2030
  • Figure 9-8: Other Monopolar Electrode Device Market, U.S., 2020 - 2030
  • Figure 9-9: Bipolar Electrode Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-10: Total Bipolar Electrode Market, U.S., 2020 - 2030
  • Figure 9-11: Bipolar Electrode Loop Market, U.S., 2020 - 2030
  • Figure 9-12: Bipolar Vaporizing Electrode Market, U.S., 2020 - 2030
  • Figure 9-13: Other Bipolar Electrode Device Market, U.S., 2020 - 2030
  • Figure 9-14: TUMT Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-15: TUMT Equipment Market, U.S., 2020 - 2030
  • Figure 9-16: TUMT Consumables Market, U.S., 2020 - 2030
  • Figure 9-17: TUNA Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-18: TUNA Equipment Market, U.S., 2020 - 2030
  • Figure 9-19: TUNA Consumables Market, U.S., 2020 - 2030
  • Figure 9-20: Temporary Prostatic Stent Market, U.S., 2020 - 2030
  • Figure 9-21: Laser BPH Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-22: Laser BPH Equipment Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-23: Total Laser BPH Equipment Market, U.S., 2020 - 2030
  • Figure 9-24: High-Power Holmium Laser Equipment Market, U.S., 2020 - 2030
  • Figure 9-25: Thulium Laser Equipment Market, U.S., 2020 - 2030
  • Figure 9-26: Total Laser BPH Fiber Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-27: Total Laser BPH Fiber Market, U.S., 2020 - 2030
  • Figure 9-28: Total Water Targeting Fiber Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-29: Total Water Target Laser BPH Fiber Market, U.S., 2020 - 2030
  • Figure 9-30: Thulium BPH Fiber Market, U.S., 2020 - 2030
  • Figure 9-31: Thulium BPH Fiber Market, U.S., 2020 - 2030
  • Figure 9-32: Hemoglobin Target Laser BPH Fiber Market, U.S., 2020 - 2030
  • Figure 9-33: UroLift Market, U.S., 2020 - 2030
  • Figure 9-34: Total Rezum(R) Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9-35: Rezum(R) Equipment Market, U.S., 2020 - 2030
  • Figure 9-36: Rezum(R) Consumables Market, U.S., 2020 - 2030
  • Figure 9-37: iTind Market, U.S., 2020 - 2030
  • Figure 9-38: Leading Competitors, BPH Treatment Device Market, U.S., 2023
  • Figure 10-1: Urological Endoscope Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 10-2: Urological Endoscope Market by Condition, U.S., 2020 - 2030 (US$M)
  • Figure 10-3: Urological Endoscope Market, U.S., 2020 - 2030
  • Figure 10-4: Cystoscope Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 10-5: Total Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-6: Single-Use Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-7: Reusable Cystoscope Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 10-8: Total Reusable Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-9: Reusable Rigid Cystoscope Market by Condition, U.S., 2020 - 2030 (US$M)
  • Figure 10-10: Total Reusable Rigid Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-11: New Rigid Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-12: Refurbished Rigid Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-13: Reusable Flexible Cystoscope Market by Condition, U.S., 2020 - 2030 (US$M)
  • Figure 10-14: Total Reusable Flexible Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-15: New Flexible Cystoscope Market by Type, U.S., 2018 - 2028 (US$M)
  • Figure 10-16: Total New Flexible Cystoscope Market, U.S., 2018 - 2028
  • Figure 10-17: New Flexible Fiber Optic Cystoscope Market, U.S., 2018 - 2028
  • Figure 10-18: New Flexible Digital Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-19: Reusable Refurbished Flexible Cystoscope Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 10-20: Total Refurbished Flexible Cystoscope Market, U.S., 2018 - 2028
  • Figure 10-21: Refurbished Flexible Fiber Optic Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-22: Refurbished Flexible Digital Cystoscope Market, U.S., 2020 - 2030
  • Figure 10-23: Ureteroscope Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 10-24: Total Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-25: Single-Use Flexible Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-26: Reusable Ureteroscope Market by Segment, U.S., 2018 - 2028 (US$M)
  • Figure 10-27: Total Reusable Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-28: Reusable Semi-Rigid Ureteroscope Market by Condition, U.S., 2020 - 2030 (US$M)
  • Figure 10-29: Total Reusable Semi-Rigid Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-30: New Semi-Rigid Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-31: Refurbished Semi-Rigid Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-32: Reusable Flexible Ureteroscope Market by Device Type, U.S., 2020 - 2030 (US$M)
  • Figure 10-33: Reusable Flexible Ureteroscope Market by Condition, U.S., 2020 - 2030 (US$M)
  • Figure 10-34: Total Reusable Flexible Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-35: Flexible Fiber Optic Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-36: Flexible Digital Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-37: New Flexible Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-38: Refurbished Flexible Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-39: Refurbished Flexible Fiber Optic Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-40: Refurbished Flexible Digital Ureteroscope Market, U.S., 2020 - 2030
  • Figure 10-41: Resectoscope Market by Segment, U.S., 2018 - 2028 (US$M)
  • Figure 10-42: Total Resectoscope Market, U.S., 2018 - 2028
  • Figure 10-43: New Resectoscope Market, U.S., 2020 - 2030
  • Figure 10-44: Refurbished Resectoscope Market, U.S., 2020 - 2030
  • Figure 10-45: Nephroscope Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 10-46: Total Nephroscope Market, U.S., 2018 - 2028
  • Figure 10-47: New Nephroscope Market, U.S., 2020 - 2030
  • Figure 10-48: Refurbished Nephroscope Market, U.S., 2020 - 2030
  • Figure 10-49: Leading Competitors, Urological Endoscope Market, U.S., 2023
  • Figure 11-1: Prostate Cancer Treatment Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-2: Brachytherapy Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-3: HDR Brachytherapy Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-4: Afterloader Market, U.S., 2020 - 2030
  • Figure 11-5: Afterloader Service Market, U.S., 2020 - 2030
  • Figure 11-6: LDR Brachytherapy Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-7: LDR Seed Market by Isotope, U.S., 2020 - 2030 (US$M)
  • Figure 11-8: LDR Seed Market by Seed Type, U.S., 2030 - 2030 (US$M)
  • Figure 11-9: Total LDR Seed Market, U.S., 2020 - 2030
  • Figure 11-10: Cs-131 Market by Seed Type, U.S., 2020 - 2030 (US$M)
  • Figure 11-11: Total Cs-131 Market, U.S., 2020 - 2030
  • Figure 11-12: Stranded Cs-131 Market, U.S., 2020 - 2030
  • Figure 11-13: Non-Stranded Cs-131 Market, U.S., 2020 - 2030
  • Figure 11-14: Pd-103 Market by Seed Type, U.S., 2020 - 2030 (US$M)
  • Figure 11-15: Total Pd-103 Market, U.S., 2020 - 2030
  • Figure 11-16: Stranded Pd-103 Market, U.S., 2020 - 2030
  • Figure 11-17: Non-Stranded Pd-103 Market, U.S., 2020 - 2030
  • Figure 11-18: I-125 Market by Seed Type, U.S., 2020 - 2030 (US$M)
  • Figure 11-19: Total I-125 Market, U.S., 2020 - 2030
  • Figure 11-20: Stranded I-125 Market, U.S., 2020 - 2030
  • Figure 11-21: Non-Stranded I-125 Market, U.S., 2020 - 2030
  • Figure 11-22: LDR Needle Market, U.S., 2020 - 2030
  • Figure 11-23: Cryotherapy Ablation Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-24: Cryotherapy Ablation Device Market, U.S., 2020 - 2030
  • Figure 11-25: Cryotherapy Ablation Device Rental Market, U.S., 2020 - 2030
  • Figure 11-26: Cryotherapy Ablation Probe Market, U.S., 2020 - 2030
  • Figure 11-27: Hydrogel Rectal Spacer Device Market, U.S., 2020 - 2030
  • Figure 11-28: Leading Competitors, Prostate Cancer Treatment Device Market, U.S., 2023
  • Figure 11-29: Leading Competitors, Brachytherapy Device Market, U.S., 2023
  • Figure 12-1: Urodynamic Equipment Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 12-2: Urodynamic Equipment Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 12-3: Total Urodynamic Equipment Market, U.S., 2020 - 2030
  • Figure 12-4: Hospital Urodynamic Capital Equipment Market, U.S., 2020 - 2030
  • Figure 12-5: Medical Office Urodynamic Capital Equipment Market, U.S., 2020 - 2030
  • Figure 12-6: Total Urodynamic Consumables Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 12-7: Total Urodynamic Consumables Market, U.S., 2020 - 2030
  • Figure 12-8: Air-Charged Catheter Market, U.S., 2020 - 2030
  • Figure 12-9: Water-Filled Catheter Market, U.S., 2020 - 2030
  • Figure 12-10: Fiber Optic Catheter Market, U.S., 2020 - 2030
  • Figure 12-11: Leading Competitors, Urodynamic Equipment Market, U.S., 2023
  • Figure 13-1: Nephrostomy Device Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 13-2: Percutaneous Nephrostomy Set Market, U.S., 2020 - 2030
  • Figure 13-3: Nephrostomy Balloon Catheter Market, U.S., 2020 - 2030
  • Figure 13-4: Nephrostomy Drainage Tube Market, U.S., 2020 - 2030
  • Figure 13-5: Leading Competitors, Nephrostomy Device Market, U.S., 2023
  • Figure 14-1: Men's Reproductive Health Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 14-2: Inflatable Erectile Dysfunction Device Market, U.S., 2020 - 2030
  • Figure 14-3: Malleable Erectile Dysfunction Device Market, U.S., 2020 - 2030
  • Figure 14-4: Vacuum Erection Device Market, U.S., 2020 - 2030
  • Figure 14-5: Testicular Implant Market, U.S., 2020 - 2030
  • Figure 14-6: Leading Competitors, Men's Reproductive Health Market, U.S., 2023
  • Figure 15-1: Urinary Guidewire Market, U.S., 2020 - 2030
  • Figure 15-2: Leading Competitors, Urinary Guidewire Market, U.S., 2023